ClinVar Genomic variation as it relates to human health
NM_178526.5(SLC25A42):c.871A>G (p.Asn291Asp)
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
No data submitted for somatic clinical impact
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_178526.5(SLC25A42):c.871A>G (p.Asn291Asp)
Variation ID: 219191 Accession: VCV000219191.30
- Type and length
-
single nucleotide variant, 1 bp
- Location
-
Cytogenetic: 19p13.11 19: 19110790 (GRCh38) [ NCBI UCSC ] 19: 19221599 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Jan 18, 2016 Feb 4, 2024 May 8, 2023 - HGVS
-
Nucleotide Protein Molecular
consequenceNM_178526.5:c.871A>G MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_848621.2:p.Asn291Asp missense NM_001321544.2:c.871A>G NP_001308473.1:p.Asn291Asp missense NC_000019.10:g.19110790A>G NC_000019.9:g.19221599A>G NG_050576.1:g.51830A>G - Protein change
- N291D
- Other names
- -
- Canonical SPDI
- NC_000019.10:19110789:A:G
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
---|---|---|---|---|---|---|
HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
SLC25A42 | - | - |
GRCh38 GRCh37 |
143 | 163 |
Conditions - Germline
Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
---|---|---|---|---|
Likely pathogenic (1) |
criteria provided, single submitter
|
Mar 31, 2014 | RCV000203566.6 | |
Pathogenic/Likely pathogenic (9) |
criteria provided, multiple submitters, no conflicts
|
May 8, 2023 | RCV000412490.20 | |
SLC25A42-related mitochondrial disorder
|
Likely pathogenic (1) |
no assertion criteria provided
|
Jan 29, 2019 | RCV000984915.4 |
Submissions - Germline
Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
---|---|---|---|---|---|
Likely pathogenic
(Mar 31, 2014)
|
criteria provided, single submitter
Method: research
|
Inborn mitochondrial myopathy
Affected status: yes
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV000258549.1
First in ClinVar: Jan 18, 2016 Last updated: Jan 18, 2016 |
|
|
Pathogenic
(Aug 30, 2019)
|
criteria provided, single submitter
Method: curation
|
Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression
Affected status: unknown
Allele origin:
unknown
|
SIB Swiss Institute of Bioinformatics
Accession: SCV000998865.1
First in ClinVar: Nov 17, 2019 Last updated: Nov 17, 2019 |
Comment:
This variant is interpreted as a Pathogenic for Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression, autosomal recessive. The following ACMG Tag(s) were … (more)
This variant is interpreted as a Pathogenic for Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression, autosomal recessive. The following ACMG Tag(s) were applied: PM2, PP3, PM3, PS3, PP1-Strong. (less)
|
|
Pathogenic
(Jun 07, 2019)
|
criteria provided, single submitter
Method: clinical testing
|
Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression
(Autosomal recessive inheritance)
Affected status: yes
Allele origin:
inherited
|
Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
Accession: SCV001149932.1
First in ClinVar: Feb 03, 2020 Last updated: Feb 03, 2020 |
Sex: male
Tissue: blood
|
|
Likely pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression
Affected status: yes
Allele origin:
germline
|
Centogene AG - the Rare Disease Company
Accession: SCV001426443.1
First in ClinVar: Aug 08, 2020 Last updated: Aug 08, 2020 |
|
|
Pathogenic
(Jan 17, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression
Affected status: yes
Allele origin:
unknown
|
Baylor Genetics
Accession: SCV001525590.1
First in ClinVar: Mar 22, 2021 Last updated: Mar 22, 2021 |
Comment:
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].
|
|
Pathogenic
(-)
|
criteria provided, single submitter
Method: clinical testing
|
Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression
Affected status: yes
Allele origin:
germline
|
Pathology and Clinical Laboratory Medicine, King Fahad Medical City
Accession: SCV002073858.1
First in ClinVar: Feb 09, 2022 Last updated: Feb 09, 2022 |
Number of individuals with the variant: 4
Ethnicity/Population group: Arab
Geographic origin: Middle East
|
|
Pathogenic
(May 08, 2023)
|
criteria provided, single submitter
Method: research
|
Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression
Affected status: yes
Allele origin:
germline
|
Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center
Accession: SCV003924288.1
First in ClinVar: May 20, 2023 Last updated: May 20, 2023 |
|
|
Pathogenic
(Dec 17, 2020)
|
criteria provided, single submitter
Method: clinical testing
|
Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression
Affected status: unknown
Allele origin:
germline
|
Revvity Omics, Revvity
Accession: SCV002020663.3
First in ClinVar: Nov 29, 2021 Last updated: Feb 04, 2024 |
|
|
Pathogenic
(Jan 01, 2016)
|
no assertion criteria provided
Method: literature only
|
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION
Affected status: not provided
Allele origin:
germline
|
OMIM
Accession: SCV000490311.3
First in ClinVar: Jan 07, 2017 Last updated: May 16, 2019 |
Comment on evidence:
In a 16-year-old boy, born of consanguineous Saudi parents, with recurrent metabolic crises with variable encephalomyopathic features and neurologic regression (MECREN; 618416), (618416), Shamseldin et … (more)
In a 16-year-old boy, born of consanguineous Saudi parents, with recurrent metabolic crises with variable encephalomyopathic features and neurologic regression (MECREN; 618416), (618416), Shamseldin et al. (2016) identified a homozygous c.871A-G transition (c.871A-G, NM_178526) in the SLC25A42 gene, resulting in an asn291-to-asp (N291D) substitution at a highly conserved residue. The mutation, which was found by exome analysis, segregated with the disorder in the family and was not found in the ExAC database or in 700 in-house control exomes. Molecular modeling suggested that the N291 residue faces the interior of the substrate-binding groove. The mutation was unable to rescue the motor-deficit phenotype in zebrafish with morpholino knockdown of the slc25a42 gene, suggesting that the mutation resulted in a loss of function. Almannai et al. (2018) identified a homozygous N291D mutation in the SLC25A42 gene in 12 patients from 8 unrelated consanguineous Middle Eastern families with MECREN. The phenotype was highly variable, even within families, and the authors suggested that exogenous factors and stressors can modulate disease severity. Functional studies of the variant and studies of patient cells were not performed. The authors referred to N291D as a founder allele in this population. Iuso et al. (2019) identified a homozygous N291D mutation in a 6-year-old boy, born of consanguineous Saudi parents, with MECREN. The mutation, which was found by exome sequencing and confirmed by Sanger sequencing, was found in heterozygous state in each unaffected parent, confirming segregation. Functional studies of the variant and studies of patient cells were not performed. (less)
|
|
Likely pathogenic
(Jan 29, 2019)
|
no assertion criteria provided
Method: clinical testing
|
SLC25A42-related mitochondrial disorder
Affected status: yes
Allele origin:
germline
|
Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City
Accession: SCV001132823.1
First in ClinVar: Jan 04, 2020 Last updated: Jan 04, 2020 |
|
|
Pathogenic
(Apr 01, 2023)
|
no assertion criteria provided
Method: clinical testing
|
Metabolic crises, recurrent, with variable encephalomyopathic features and neurologic regression
Affected status: yes
Allele origin:
germline
|
Clinical Laboratory Sciences Program (CLSP), King Saud bin Abdulaziz University for Health Sciences (KSAU-HS)
Accession: SCV003927928.1
First in ClinVar: Sep 16, 2023 Last updated: Sep 16, 2023 |
|
|
click to load more click to collapse |
Germline Functional Evidence
There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Citations for germline classification of this variant
HelpTitle | Author | Journal | Year | Link |
---|---|---|---|---|
Autozygome and high throughput confirmation of disease genes candidacy. | Maddirevula S | Genetics in medicine : official journal of the American College of Medical Genetics | 2019 | PMID: 30237576 |
A Homozygous Splice Site Mutation in SLC25A42, Encoding the Mitochondrial Transporter of Coenzyme A, Causes Metabolic Crises and Epileptic Encephalopathy. | Iuso A | JIMD reports | 2019 | PMID: 29923093 |
Expanding the phenotype of SLC25A42-associated mitochondrial encephalomyopathy. | Almannai M | Clinical genetics | 2018 | PMID: 29327420 |
Mutation of the mitochondrial carrier SLC25A42 causes a novel form of mitochondrial myopathy in humans. | Shamseldin HE | Human genetics | 2016 | PMID: 26541337 |
Text-mined citations for rs864321624 ...
HelpRecord last updated Aug 04, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.